Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment

Article OPEN
Buchanan, JR; Wordsworth, S; Schuh, A;

Background Genomic information could help to reduce the morbidity effects of inappropriate treatment decisions in many disease areas, in particular cancer. However, evidence of the benefits that patients derive from genomic testing is limited. This study evaluated patie... View more
  • References (51)
    51 references, page 1 of 6

    1. National Institute for Health and Care Excellence. Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care 2006.

    2. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008;24(3):133-41. doi:10.1016/ j.tig.2007.12.007.

    3. Ioannidis JPA, Khoury MJ. Are randomized trials obsolete or more important than ever in the genomic era? Genome Medicine. 2013;5(4):32. doi:10.1186/Gm436.

    4. Buchanan J, Wordsworth S, Schuh A. Issues surrounding the health economic evaluation of genomic technologies. Pharmacogenomics. 2013;14(15):1833-47. doi:10.2217/pgs.13.183.

    5. Foster MW, Mulvihill JJ, Sharp RR. Evaluating the utility of personal genomic information. Genet Med. 2009;11(8):570-4. doi:10.1097/GIM.0b013e3181a2743e.

    6. Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, Richards CS, et al. Improving the efficiency and relevance of evidencebased recommendations in the era of whole-genome sequencing: an EGAPP methods update. Genet Med. 2013;15(1):14-24. doi:10.1038/gim.2012.106.

    7. Giacomini M, Miller F, O'Brien BJ. Economic considerations for health insurance coverage of emerging genetic tests. Community Genet. 2003;6(2):61-73.

    8. Grosse SD, Wordsworth S, Payne K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med. 2008;10(9):648-54. doi:10.1097/GIM. 0b013e3181837217.

    9. Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care. 1997;13(01):21-34. doi:10.1017/ S0266462300010205.

    10. de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145-72. doi:10.1002/hec.1697.

  • Metrics
    No metrics available